Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2020-05-22 Major Shareholding Noti…
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure submitted to the National Stock Exchange of India Limited under Regulation 30(3) in compliance with SEBI (SAST) Regulations, 2011. It details the shareholding of promoters and persons acting in concert as of 31st March 2020. The content includes specific shareholding percentages and names of promoters, indicating a notification of changes or status of major shareholdings. There is no indication of financial statements, audit information, earnings data, or management discussion. The document is a regulatory disclosure about substantial acquisition of shares and takeovers, which aligns with the category of Major Shareholding Notification (MRQ). The document length is substantial (15,000 characters), and it contains detailed shareholding data, not just an announcement or certification. Therefore, the appropriate classification is MRQ with high confidence.
2020-05-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74 of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2020. It is a compliance certificate from the Registrar and Share Transfer Agent confirming dematerialization and listing of securities. The document is short (2429 characters) and primarily a regulatory compliance certificate, not a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document rather than a report or announcement of financial results or corporate actions.
2020-05-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notice from Arvee Laboratories informing the postponement of an Extraordinary General Meeting (EGM) originally scheduled for April 20, 2020, due to lockdown. It does not contain any financial data, detailed report content, or voting results. It is an announcement related to a meeting schedule change, not the meeting materials or results themselves. The document length is only 1023 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-04-20 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification from Arvee Laboratories regarding the closure of the trading window and the scheduling of a board meeting to consider and approve audited financial results for the half year and year ended March 31, 2020. It references regulatory compliance with SEBI insider trading regulations and informs the stock exchange (NSE Limited) about the trading restrictions. The document does not contain any financial data or results itself, nor does it include the actual financial report. It is a short notice about an upcoming event and trading restrictions related to the financial results announcement. Therefore, it is an announcement related to trading and board meeting scheduling, not a financial report or earnings release. Given the nature and length of the document, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice.
2020-03-30 English
Outcome of Board Meeting
Regulatory Filings Classification · 90% confidence The document text is extremely short (121 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report title, regulatory references, or any descriptive text. Given the lack of content, it cannot be classified as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient content documents.
2020-03-21 English
Board Meeting — Other business matters
Regulatory Filings Classification · 100% confidence The document text is extremely short (74 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific filing type. Given the lack of content, the document does not fit any specific category and defaults to the fallback category for miscellaneous filings.
2020-03-16 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.